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Cesare R. Sirtori, PhD, MD; Elena Tremoli, PhD
Background and Purpose—The intima-media thickness (IMT) of extracranial carotid arteries determined by B-mode
ultrasound is a measurable index of the presence of atherosclerosis. The ultrasonographic scan protocol and the scan
reading techniques used until now to measure IMT are, however, time consuming and require the participation of
specialized research centers. In this study we present a cross-sectional study of 963 patients attending the Enrica Grossi
Paoletti Center in Milan, Italy, with the aim of assessing whether ultrasonographic measurements of carotid artery in
routine clinical practice can yield the same results as those obtained with quantitative methods used until now in
clinical trials.
Methods—Maximum and mean maximum IMT of carotid arteries were assessed by B-mode ultrasound with the use of the
electronic caliper of the machine in real time.
Results—The intraobserver and interobserver variability of IMT of carotid arteries performed with the electronic caliper
in real time was similar to that of quantitative processing of frozen images (coefficients of variation of intraobserver and
interobserver mean maximum IMT measurements were 4.2% and 7.3%, respectively). Carotid artery IMT thus
measured correlated with most of the known atherosclerosis risk factors and discriminated between patients with and
without previous history of cardiovascular events. IMT was linearly related to the total number of vascular risk factors
both in the whole group and after stratification of patients into 3 age classes.
Conclusions—–These observations establish a strong correlation between B-mode imaging of carotid atherosclerosis
evaluated in normal clinical practice and data provided by clinical trials and validate this simple reading technique as
a means of identifying IMT as another possible risk factor in patients at high risk of vascular disease. (Stroke.
2000;31:2426-2430.)
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The intima-media thickness (IMT) of extracranial carotidarteries provides an index of atherosclerosis in other
vascular regions1–5 and has been shown to be associated with
most risk factors for atherosclerosis.6–8 Recently, an in-
creased thickness of carotid IMT determined by B-mode
ultrasound has been shown to be directly associated with an
increased risk of myocardial infarction and stroke in older
adults without a previous history of cardiovascular disease.9
Thus, carotid artery IMT has been proposed as a risk factor
that may be included in the algorithms for cardiovascular risk
assessment.9 However, the ultrasonographic scan protocol
and the scan reading techniques used until now are time
consuming and require the participation of highly specialized
research centers. Large-scale epidemiological studies testing
the connection between conventional or unconventional risk
factors and carotid atherosclerosis would become more fea-
sible if simpler methods were available to measure carotid
IMT, possibly during normal clinical practice. Some authors,
to shorten the time for image processing, have limited the
number of carotid segments to a single sector, eg, the first
centimeter of the common carotid. This approach, however,
may result in a loss of information and patient
misclassification.
We have investigated whether carotid IMT, measured with
an electronic caliper, a method feasible in routine clinical
practice, provides suitable information to associate carotid
IMT with a patient’s risk profile.
Subjects and Methods
Nine hundred sixty-three consecutive patients (487 men and 476
women) attending for the first time the Ultrasound Laboratory of the
E. Grossi Paoletti Center for metabolic studies (Niguarda Hospital,
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Milan, Italy) were analyzed by carotid B-mode ultrasound imaging.
The carotid IMT10 was determined manually in real time. Clinical
and laboratory parameters were simultaneously assessed. Oral in-
formed consent was obtained from all patients; the study was
approved by the Institutional Review Board.
Patients were on a low-fat diet (26% lipids, 22% proteins, 52%
carbohydrates; polyunsaturated/saturated fat ratio 0.43) for at least 3
months. Six hundred sixty-eight patients were hyperlipidemic (443
type IIa, 164 type IIb, 2 type III, 55 type IV, and 4 type V) according
to World Health Organization criteria11; 245 were borderline hyper-
lipidemic (plasma LDL cholesterol, 4.14 to 4.92 mmol/L; triglycer-
ides, 1.70 to 2.05 mmol/L), and 50 had normal lipid levels. Three
hundred three patients (31.5%) were hypertensive (systolic or dia-
stolic blood pressure .160 mm Hg and .90 mm Hg, respectively,
or under treatment with hypotensive drugs). Fifty-eight patients (6%)
were diabetic and on oral hypoglycemic therapy. One hundred
thirty-nine patients (14.4%) had a previous history of coronary heart
disease (CHD), 93 (9.7%) of cerebrovascular disease (CVD), and
150 (15.6%) of peripheral arterial disease (PAD). Eighty-two pa-
tients had xanthomas, 48 xanthelasmas, and 146 a corneal arcus.
Most of the patients had a family history of ischemic vascular
disease: 43.6% for CHD, 27.6% for CVD, and 6.4% for PAD. More
than a third of the patients were being treated with hypolipidemic
drugs (statins, resins, probucol, or fibrates); 25% with hypotensive
drugs (b-blockers, calcium antagonists, angiotensin-converting en-
zyme inhibitors, or diuretics); 20% with antiplatelet drugs; 5.7% with
oral anticoagulants; 6% with hypoglycemic drugs (insulin or met-
formin); and ,2% with uricosuric drugs or with hormonal replace-
ment therapy. Two hundred seventeen patients were current smokers
(186 hypercholesterolemic, 31 normocholesterolemic), and 274 were
previous smokers (at least 1 year after smoking cessation).
To investigate the relationship between the number of vascular
risk factors and carotid atherosclerosis, we classified each patient
according to the presence of single or multiple vascular risk factors,
arbitrarily assigning to each risk factor an equal weight. Patients
were considered to be exposed to a risk factor when 1 of the
following criteria was satisfied: male sex or at least 5 years after
menopause for women; age .55 years; LDL cholesterol
.4.14 mmol/L; triglycerides .2.28 mmol/L; HDL cholesterol
,0.91 or ,1.04 mmol/L in men and women, respectively; hyper-
tension; diabetes; smoking habit; or family history of cardiovascular
disease. In addition, patients with diabetes (cases; n558) were
compared with 116 patients (controls) matched for age, sex, and total
cholesterol levels. The same case-control protocol was applied to
patients with hypertension, CHD (angina, myocardial infarction),
CVD (stroke, transient ischemic attack), or PAD.
Lipids
Blood samples were collected from the antecubital vein after
overnight fasting. Total and HDL cholesterol and triglyceride levels
were determined in fresh serum by enzymatic methods12,13; HDL
levels were obtained by selective precipitation with dextran-MgCl2.14
Serum LDL cholesterol levels were calculated by Friedewald’s
formula.15
Ultrasound Protocol
Ultrasound examination was performed with the use of an 8-MHz
annular array ultrasound imaging system (2000 II s.a., Biosound) by
a single trained sonographer. With this technique, 2 parallel echo-
genic lines separated by an anechoic space can be visualized at levels
of the artery wall. It was previously shown that these lines were
generated by the blood-intima and media-adventitia interfaces.10 The
distance between the 2 lines gives a reliable index of the thickness of
the intimal-medial complex.10 Subjects were examined in the supine
position. Ultrasound scans of the right and left last distal centimeter
of common carotid arteries and bifurcation and of the first proximal
centimeter of internal carotid arteries in 3 different projections
(anterior, lateral, and posterior) were performed. All measurements
were made at the time of scanning on unfrozen images of longitu-
dinal scans by using the machine’s electronic caliper. Six carotid
segments for each projection (near and far walls of bulb and internal
and common carotid arteries) were examined. The maximal IMT
value of each segment was measured. The complete procedure is
generally performed in approximately 30 to 35 minutes. IMT values
for the 3 different projections and for right and left carotid arteries
were averaged to obtain the mean maximum IMT (MM-IMT). A
total of 11 566 carotid segments were imaged, and there were 544
instances of missing data (4.7%). The analysis presented in this
report provides substantially identical results when patients with
missing data are either considered or excluded. In addition, a pilot
study was performed in a random sample of 100 patients of the
overall study group. The mean MM-IMT of these subjects did not
significantly differ from that calculated after a random deletion of the
5% of observations. Thus, in the MM-IMT assessment, values are
presented that include patients with missing data. The highest IMT
value found among the 36 segments was defined as the maximal IMT
(Max-IMT). For the assessment of interobserver and intraobserver
variability of carotid measurements, 20 patients of the study group
underwent 2 carotid ultrasound investigations 2 weeks apart. Ultra-
sound investigation was performed twice at each visit by 2 trained
sonographers.
Statistical Analysis
Mean6SD values were used as descriptive measures of normally
distributed variables. Because of the highly skewed distribution of
triglycerides, these values were log transformed, which yielded an
almost gaussian distribution. Groups were compared by ANCOVA.
Differences in categorical variables were analyzed by the x2 test.
Correlation was analyzed by the nonparametric Spearman method.
Results
Table 1 shows the intraobserver and interobserver variability
of IMT of carotid arteries performed with the electronic
caliper in real time. The reproducibility was similar to that of
quantitative processing of frozen images.16 In particular,
coefficients of variation of intraobserver and interobserver
MM-IMT measurements were 4.2% and 7.3%, respectively.
Table 2 shows the characteristics of the population studied.
Men in the group were younger than women, had the greatest
body mass index (BMI), and presented the greatest percent-
age of smokers. They had, however, lower values of total,
LDL, and HDL cholesterol and higher values of triglycerides
and blood glucose than the women. MM-IMT and Max-IMT
values were greater in men than in women. Carotid IMT
values correlated highly with age in the total population
(r50.43 and r50.46 for Max-IMT and MM-IMT, respec-
tively; P,0.0001).
The relationship of carotid IMT to the different variables
was then evaluated after adjustment for age. Carotid IMT
significantly and positively correlated with systolic blood
TABLE 1. Intraobserver and Interobserver Variability of IMT
Determined With the Electronic Caliper (n520)
Mean6SD
Difference, mm* CV, % r
Intraobserver
MM-IMT 0.0460.02 4.2 0.95
Max-IMT 0.1860.22 12.9 0.94
Interobserver
MM-IMT 0.0760.05 7.3 0.96
Max-IMT 0.1760.18 8.5 0.78
CV indicates coefficient of variation.
*Differences between replicate scans.
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pressure, total cholesterol, LDL cholesterol, triglycerides, and
blood glucose and negatively with HDL cholesterol (Table 3).
The Figure shows that MM-IMT and Max-IMT values
increased with the number of risk factors, with the greatest
IMT occurring in patients with .4 risk factors (P,0.003 and
P,0.015 for MM-IMT and Max-IMT, respectively). The
relationship between carotid IMT and the number of risk
factors was also observed after stratification of patients into 3
age groups (data not shown).
Case-control analysis (Table 4) showed that hypertensive
patients had greater IMT. They also differed from the
corresponding controls in BMI, triglycerides, and blood
glucose. In diabetic patients, by contrast, no significant
difference in carotid parameters was found, despite the
presence of higher BMI, higher serum triglycerides, and
lower levels of HDL cholesterol.
Table 5 shows that patients with CHD and patients with
PAD had greater values of MM-IMT and Max-IMT than
corresponding controls, whereas no difference in MM-IMT
and Max-IMT was found between patients with CVD and
controls.
Discussion
These data demonstrate that IMT measured by a simple
method for image processing, which can be performed
directly during scanning of the carotid arteries, can provide a
reliable index of carotid atherosclerosis. In a population of
963 patients attending a lipid clinic, IMT values of carotid
arteries determined in real time with the electronic caliper (1)
correlated with most atherosclerosis risk factors, (2) were
associated with the number of atherosclerosis risk factors, and
(3) discriminated between patients with and without previous
history of cardiovascular events. The precision of the method
(approximately 0.1 mm) is lower than that of more sophisti-
cated quantitative methods (0.02 to 0.06 mm),16 but our data
suggest that this does not represent a real limitation when an
adequate patient sample is used.
In agreement with previous reports, we found statistically
significant differences between men and women in carotid
IMT.4,8,17 The correlation coefficients between Max-IMT or
MM-IMT and age (r50.43 and r50.46, respectively) were
similar to the mean value of correlation coefficients reported
by 5 studies (r50.48).18–22
Direct and significant correlations between carotid IMT and
systolic blood pressure, total cholesterol (age-adjusted Max-IMT
only), LDL cholesterol, triglycerides, blood glucose (age-
adjusted Max-IMT only), and HDL cholesterol (inversely) were
found, all in accordance with previously reported findings.20,23,24
Again in accordance with previous findings,20,24–26 IMT was
greater in hypertensive patients. On the contrary, no difference
was found between diabetic and nondiabetic patients; the high
prevalence of these patients with hypercholesterolemia may
have masked the effect of diabetes on carotid IMT.27,28
Results of the British Regional Heart Study6 suggest that
the presence of plaque, but not IMT, is associated with high
risk of disease. In our study Max-IMT but also MM-IMT
allowed us to identify groups of patients with previous
cardiovascular events, ie, CHD or PAD. We suggest that
MM-IMT and/or Max-IMT may represent comprehensive
indices of atherosclerosis and that, when a normogram in
different types of patients has been defined, they will help
clinicians to identify groups of patients likely to benefit from
aggressive preventive measures.
Max-IMT (left) and MM-IMT (right) in relation to number of vas-
cular risk factors.
TABLE 3. Spearman Correlation Coefficients Among
Age-Adjusted MM-IMT, Max-IMT, and Clinical and
Laboratory Variables
MM-IMT
(Age Adjusted)
Max-IMT
(Age Adjusted)
BMI NS NS
SBP 0.14§ 0.19§
DBP NS NS
Total cholesterol NS 0.10†
LDL cholesterol 0.10† 0.13‡
HDL cholesterol 20.22§ 20.22§
Triglycerides 0.08* 0.07*
Blood glucose NS 0.09*
*P,0.05; †P,0.01; ‡P,0.001; §P,0.0001.
TABLE 2. Characteristics of Patients in the Overall Group and
After Stratification by Sex
Total Group
(n5963)
Women
(n5476)
Men
(n5487)
Age, y 54.6611.7 56.2611.8 53.0611.3†
Smokers, % 22.5 14.3 30.6†
BMI, kg/m2 24.063.1 23.463.3 24.662.8†
SBP, mm Hg 135.1618.0 135.1618.9 135.1617.1
DBP, mm Hg 82.969.6 82.769.5 83.269.6
Total
cholesterol, mmol/L
6.8561.47 7.0661.38 6.6461.54*
LDL cholesterol, mmol/L 4.8061.43 4.9861.40 4.6061.43†
HDL
cholesterol, mmol/L
1.3460.36 1.4760.34 1.2160.32†
Triglycerides, mmol/L 1.8562.51 1.5260.82 2.1863.43†
Blood glucose, mmol/L 5.2360.77 5.1360.77 5.3460.76†
MM-IMT (age adjusted),
mm
0.8560.33 0.7760.29 0.9260.36†
Max-IMT (age adjusted),
mm
1.6960.91 1.4860.80 1.9060.97*
Data, with the exception of smoking habit, are mean6SD. SBP and DBP
indicate systolic and diastolic blood pressure, respectively.
*P,0.001, †P,0.0001 vs women. Differences in IMT have been assessed
by ANCOVA after adjustment of data for age, smoking, BMI, total cholesterol,
LDL cholesterol, HDL cholesterol, triglycerides, and blood glucose.
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Carotid IMT increased with the number of concurrent risk
factors, even after stratification of patients for age, a further
indication that MM-IMT and Max-IMT may represent com-
prehensive indices of carotid and even more widespread
atherosclerosis.
The data discussed in this report strongly suggest that mea-
surement of IMT with the electronic caliper is a method feasible
in routine clinical practice and provides suitable information to
associate carotid IMT with the risk profile of different groups of
patients. By the use of this simple methodology, as a result of the
TABLE 4. Characteristics of Subjects With (Cases) and Without (Controls) Hypertension
and Diabetes
Hypertension Diabetes
Controls Cases Controls Cases
n 458 229 116 58
Men, %* 51.9 51.9 63.7 63.7
Age, y* 57.368.5 57.368.5 59.468.7 59.468.8
Smokers, % 22.1 21.8 13.8 34.5
BMI, kg/m2 23.863.0 24.863.2§ 24.462.7 25.463.7†
SBP, mm Hg 130.4614.6 145.9618.3¶ 138.2615.5 141.4619.5
DBP, mm Hg 81.368.3 87.569.5¶ 83.068.2 84.968.5
Total cholesterol, mmol/L* 6.7461.39 6.9161.32 6.6461.57 6.4561.06
LDL cholesterol, mmol/L 4.6461.26 4.7861.3 4.6061.63 4.3660.73
HDL cholesterol, mmol/L 1.3660.37 1.3260.35 1.3360.34 1.1260.37†
Triglycerides, mmol/L 1.8062.84 2.2963.19§ 1.5660.92 3.1862.40§
Blood glucose, mmol/L 5.2260.72 5.4661.03‡ 5.4260.57 7.6061.85¶
MM-IMT, mm 0.8260.35 0.9460.40§ 1.0060.48 1.0460.41
Max-IMT, mm 1.6360.95 2.0261.08§ 1.8861.06 2.1661.11
Data are mean6SD.
*Matched variable.
†P,0.05, ‡P,0.01, §P,0.0001 vs controls. For hypertension, IMT differences have been assessed after
adjustment of data for matching variables and for BMI, triglycerides, and blood glucose. For diabetes, differences in
IMT values have been assessed after adjustment of data for matching variables and for BMI, HDL cholesterol, and
triglycerides.
¶Differences result from selection of the studied group.
TABLE 5. Characteristics of Subjects With (Cases) and Without (Controls) CHD, CVD, and PAD
CHD CVD PAD
Controls Cases Controls Cases Controls Cases
n 266 133 186 93 244 122
Men, %* 76.0 76.0 60.2 60.2 69.7 69.7
Age, y* 57.569.3 57.569.3 59.867.8 59.867.8 59.067.6 59.067.6
Smokers, % 29.7 22.6 23.7 26.9 33.5 41.2
BMI, kg/m2 24.463.0 24.663.0 24.863.0 24.563.5 24.562.8 24.863.1
SBP, mm Hg 138.8619.2 138.9619.4 142.2617.0 144.0621.5 137.9617.9 143.6616.1‡
DBP, mm Hg 84.169.7 82.869.6 85.168.1 84.468.7 84.469.3 84.067.7
Total cholesterol, mmol/L* 6.7161.37 6.7061.64 6.5861.20 6.8061.42 6.6561.14 6.5961.33
LDL cholesterol, mmol/L 4.6561.34 4.5761.35 4.5761.11 4.7261.30 4.5861.12 4.4661.12
HDL cholesterol, mmol/L 1.2860.33 1.2360.35 1.2860.35 1.2260.36 1.3360.33 1.1960.34‡
Triglycerides, mmol/L 2.0362.63 1.9861.45 1.9861.45 1.9161.08 1.7460.84 2.7164.55‡
Blood glucose, mmol/L 5.2960.72 5.4060.98 5.5060.97 5.1960.62 5.3460.77 5.3960.80
MM-IMT, mm 0.9460.38 1.0860.49† 1.0260.40 1.1060.50 0.8660.33 1.1660.42§
Max-IMT, mm 1.9461.03 2.3661.19† 2.1261.08 2.3461.10 1.7560.97 2.4761.09§
Data are mean6SD.
*Matched variable.
†P,0.05, ‡P,0.01, §P,0.0001 vs controls. IMT differences have been observed after adjustment of data for matching factors. For PAD, IMT
differences have been observed after adjustment of data for matching factors and for SBP, HDL cholesterol, and triglycerides.
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reduction in time and costs, it is possible to extend the analysis
of arterial wall thickness to the whole carotid tree, instead of
selecting a single segment. However, to perform such studies
properly, the following aspects should be carefully taken into
account. First, the training of sonographers/readers for each
study should be considered, and changes over time in sonogra-
pher/reader behavior should also be taken into account. More-
over, in studies involving different sonographers, interobserver
variability should be carefully determined. Finally, in longitudi-
nal and/or pharmacological studies, the use of this technique
should not be allowed until appropriate validation is performed.
In conclusion, we have shown that measurement of the
IMT of carotid arteries with an electronic caliper is a rapid,
low-cost method that provides information similar to that
obtained by more precise methods. This approach should
prove useful in large clinical and/or epidemiological trials in
which the evaluation of arterial wall morphological targets
using more sophisticated methods for IMT measurement is
not practical because of cost and time constraints.
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